Hyrox and Xenom: The Ambition to Make Fitness Racing the 'Largest Sport on Earth'

Last month, when Xenom held its second event in London, 560 athletes ran. That was roughly 40 per cent higher than the 400 athletes at its first event in Dallas. The company's CEO, Keith Barlow, called it "roughly 30 per cent growth." Two events, 960 athletes in total, and a seed funding round of $15 million. Meanwhile, the founders of Hyrox, the world's largest fitness racing company, invested in Xenom. The amount was not disclosed. This story is not just about a startup; it is about how fitness racing is trying to prove itself as "the largest sport on earth." I have tracked the economic models of mass-participation events for years, and this case refreshes all the old questions: when does a fitness revolution become a sport, and when does it remain a branded workout?

What is Hyrox? It is a standardised fitness racing format: eight stations, combining running and functional workouts, with four competitive categories. The eight stations are ski erg, sled push, sled pull, burpee broad jumps, rowing, farmers carry, sandbag lunges and wall balls. Each station is separated by one kilometre of running. In total, eight kilometres of running and eight functional exercises. This season the company has held more than 100 events, including in cities such as London and Rio, and is targeting around 2.2 million participants. Xenom, founded in 2026, is a new company that runs ten standardised events over two days in a "CrossFit-inspired" format. It has held only two events so far – Dallas in June and London. Miami in December, and its first full international season in 2027, opening in Malaga. The partnership between the two companies was announced in October 2026, covering marketing, events and education. Xenom's board already includes WndrCo (Jeffrey Katzenberg), Sujay Jaswa (who led the $15 million seed round) and its own CEO, alongside media and tech expertise. Now it also includes Hyrox founders Moritz Fuerste and Toetzke.

Hyrox's real strength is the standardisation of the format, not the athleticism. Eight stations, fixed loads and fixed distances mean that performances from participants around the world can be compared on a global leaderboard. That is the most valuable asset for sponsorship, broadcast and Olympic eligibility. It is the same "one-design" logic that made franchise motorsport and mass marathons commercially scalable. Hyrox's four-category structure (open, pro, doubles, relay) is a demand-side masterstroke: it turns a punishing elite test into an accessible consumer product, so first-timers, teams and elites can all participate together. That is why Hyrox's participation is nearly two thousand times that of Xenom. However, it is worth noting that Hyrox's figures are also self-reported. The 2.2 million figure is for "this season," while the 2.5 million target for 2027 is for "calendar year." That is comparing apples to oranges – different time windows, different event counts. The apparent 13.6 per cent growth is not like-for-like and should not be annualised.

Xenom's two-day, ten-event format is deliberately different, but it carries a structural handicap. Two days mean more time and travel cost for athletes, and more expense for the host city. Broadcast packaging also becomes complicated. Hyrox has engineered these frictions out. Xenom's differentiation here may slow scaling, not accelerate it. However, the company's bet is that it can capture the "CrossFit-inspired" community without infringing on CrossFit's intellectual property. That is a smart brand-adjacency strategy, but legal and community risks remain. Xenom's figures also contain an inconsistency: 400 to 560 shows 40 per cent growth, but the CEO calls it "roughly 30 per cent." Both figures cannot be precise at the same time. And most importantly: n=2. A 30–40 per cent jump between two events is not a growth rate; it is a launch artefact – novelty, city selection (London is a deeper market than Dallas), calendar placement. Any trend claim from this base is unsupportable.

The real meaning of the partnership is a "call option." Hyrox's founders invested in Xenom and gained a board seat. It is clear that Hyrox has made a cheap bet on Xenom's format and community, while Xenom gets credibility, a distribution channel and a big name. Neither side has committed disclosed capital, keeping downside limited. But the most important fact – the investment amount – is unknown. Without it, no valuation or strategic commitment can be assessed. This deal is a minority strategic stake, not an acquisition. Hyrox has its event machinery and education pipeline; Xenom has novelty and a new format. But remember: Hyrox's founders now sit on the board of a potential future competitor. That is a classic governance risk.

The biggest missing metric is retention rate. For any subscription-like business, churn determines whether growth compounds or is rented. Neither Hyrox nor Xenom has disclosed repeat participation, sell-out rates, waitlists or revenue per participant. That is a sign of deliberately chosen metrics. I have tracked the economic models of mass-participation events for years, and this is where most fitness startups fail – they show participation numbers, but not how many come back. Hyrox's geographic expansion is towards South America (Argentina, Brazil), then Central America and Mexico. That is expansion into lower-income, lower-price-point markets, which typically compresses revenue per participant even as total participation rises. So watch for a headcount-up, revenue-per-head-down divergence. For Xenom, the larger field in London is most likely due to market depth and existing Hyrox-style gym penetration in the UK, not Xenom-specific brand pull.

There is serious doubt about the Olympic ambition. Moritz Fuerste, co-founder of Hyrox and an Olympic gold medallist, himself says: "Is it super likely? I don't know." That is a rare and valuable admission that weakens the Olympic headline. Fitness racing has no recognition from the International Olympic Committee (IOC), and the path to Brisbane 2032 is not clear. This may be a marketing narrative, not a real sports-governance strategy. Fuerste's doubt reflects his honesty, but it also exposes the credibility of the whole story. My first live mic taught me to leave space for doubt, and the same lesson applies here: when someone talks about the Olympics, ask which door, in which year, and through which authority.

Keith Barlow says Hyrox and Xenom are "separate but connected markets on the same spectrum." That is a supplier-side argument. Consumers have a time and money budget, not a "spectrum." In practice, both properties compete for the same discretionary spend and the same sponsor categories. If a consumer spends money on Hyrox, they will not spend it on Xenom. So the partnership is more a long-term option than a collaborative effort. And here another Hyrox vulnerability is exposed: the format is easy to replicate. The barriers to replicating eight stations are near zero. What remains is brand, event operations and a gym-affiliation network – not the sport. This is a distribution business wearing a sports costume.

In 2027, Xenom's first full international season will begin, opening in Malaga. The Miami event in December 2026 will be a crucial test. If more than 1,000 athletes do not show up there, the real value of the partnership will be in doubt. For Hyrox, the target of 2.5 million participants by 2027 is ambitious, but if they only increase event count, per-event participation may fall. My forecast is that Hyrox will land between 2.3 and 2.4 million in 2027, and Xenom will reach 1,500–2,000 athletes. If this proves wrong, the biggest lesson will be that fitness racing is still a fashion, not a sport. And if it proves right, then perhaps we are witnessing the rise of a new sport. But until then, given the lack of data and the Olympic uncertainty, this story is still in its second chapter. I drew the data framework before I understood the story, and that framework is still incomplete.